Standard Versus Reduced-Doses of Post-Transplant Cyclophosphamide in HLA Matched (10/10) Peripheral Blood Stem Cell Transplantation Eur J Haematol
Induction therapy with bortezomib, melphalan, and prednisone followed by lenalidomide and dexamethasone versus carfilzomib, lenalidomide, and dexamethasone with or without daratumumab in older, fit patients with newly diagnosed multiple myeloma (GEM-2017FIT): a phase 3, open-label, multicentre, randomised clinical trial Lancet Haematol
Variations in Innate Immune Cell Subtypes Correlate with Epigenetic Clocks, Inflammaging and Health Outcomes ADV SCI
The impact of cancer survivors' extra risk of non-cancer mortality on net survival estimation Am J Epidemiol
Implementation of the precision oncology program in catalonia's public health system: results, lessons learned, and future prospects Clin Transl Oncol
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGvHD biomarkers Blood Adv
The Discovery, Characterization, and Quantification of Bioactive Peptides Contained in Palbio Porcine Intestinal Mucosa Hydrolysate Products Int J Mol Sci
Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia Blood Neoplasia